In the original version of this Article, the affiliation details for Yan Huang and Li Zhang were incorrectly given as ‘Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China’, and should have been ‘State Key Laboratory of Oncology in South China, Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China’. This has now been corrected in both the PDF and HTML versions of the Article.
Additional information
The online version of the original article can be found at https://doi.org/10.1038/ncomms15870
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Cai, J., Fang, L., Huang, Y. et al. Correction: Publisher Correction: Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC. Nat Commun 9, 16196 (2018). https://doi.org/10.1038/ncomms16196
Published:
DOI: https://doi.org/10.1038/ncomms16196
This article is cited by
-
WNT ligands in non-small cell lung cancer: from pathogenesis to clinical practice
Discover Oncology (2023)
-
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
Signal Transduction and Targeted Therapy (2022)
-
Non-coding RNAs in Wilms’ tumor: biological function, mechanism, and clinical implications
Journal of Molecular Medicine (2021)
-
Noncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application
Molecular Cancer (2020)
-
MicroRNA-122 negatively associates with peroxiredoxin-II expression in human gefitinib-resistant lung cancer stem cells
Cancer Gene Therapy (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
